These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 17689069

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer.
    Karazanashvili G, Abrahamsson PA.
    J Urol; 2003 Feb; 169(2):445-57. PubMed ID: 12544286
    [Abstract] [Full Text] [Related]

  • 3. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
    Jansen FH, Roobol M, Jenster G, Schröder FH, Bangma CH.
    Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
    [Abstract] [Full Text] [Related]

  • 4. Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer.
    Stephan C, Jung K, Lein M, Sinha P, Schnorr D, Loening SA.
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1133-47. PubMed ID: 11097220
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Prostate cancer and prostate specific antigen screening].
    Camici M.
    Minerva Med; 2004 Feb; 95(1):25-34. PubMed ID: 15041924
    [Abstract] [Full Text] [Related]

  • 9. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
    Steuber T, Niemela P, Haese A, Pettersson K, Erbersdobler A, Felix Chun KH, Graefen M, Kattan MW, Huland H, Lilja H.
    Prostate; 2005 Apr 01; 63(1):13-8. PubMed ID: 15378521
    [Abstract] [Full Text] [Related]

  • 10. Prostate specific antigen: an updated review.
    So A, Goldenberg L, Gleave ME.
    Can J Urol; 2003 Dec 01; 10(6):2040-50. PubMed ID: 14704108
    [Abstract] [Full Text] [Related]

  • 11. The value of (-7, -5)pro-prostate-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer.
    Bangma CH, Wildhagen MF, Yurdakul G, Schröder FH, Blijenberg BG.
    BJU Int; 2004 Apr 01; 93(6):720-4. PubMed ID: 15049979
    [Abstract] [Full Text] [Related]

  • 12. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
    Stephan C, Jung K, Nakamura T, Yousef GM, Kristiansen G, Diamandis EP.
    Int J Urol; 2006 Mar 01; 13(3):238-43. PubMed ID: 16643616
    [Abstract] [Full Text] [Related]

  • 13. [Recent advances in proPSA on early detection in prostate cancer].
    Zhu PY, Hong P, Huang YF.
    Zhonghua Nan Ke Xue; 2005 Dec 01; 11(12):944-6. PubMed ID: 16398372
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of serum markers for prostate cancer.
    Stenman UH, Abrahamsson PA, Aus G, Lilja H, Bangma C, Hamdy FC, Boccon-Gibod L, Ekman P.
    Scand J Urol Nephrol Suppl; 2005 May 01; (216):64-81. PubMed ID: 16019759
    [Abstract] [Full Text] [Related]

  • 15. On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
    Bangma CH, van Schaik RH, Blijenberg BG, Roobol MJ, Lilja H, Stenman UH.
    Eur J Cancer; 2010 Nov 01; 46(17):3109-19. PubMed ID: 21047594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Indications and timing for prostate biopsy, diagnosis of early stage prostate cancer and its definitive treatment: a clinical conundrum in the PSA era.
    Punnen S, Nam RK.
    Surg Oncol; 2009 Sep 01; 18(3):192-9. PubMed ID: 19282170
    [Abstract] [Full Text] [Related]

  • 18. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
    Lilja H, Ulmert D, Björk T, Becker C, Serio AM, Nilsson JA, Abrahamsson PA, Vickers AJ, Berglund G.
    J Clin Oncol; 2007 Feb 01; 25(4):431-6. PubMed ID: 17264339
    [Abstract] [Full Text] [Related]

  • 19. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
    Fitzpatrick JM, Banu E, Oudard S.
    BJU Int; 2009 Mar 01; 103(5):578-87. PubMed ID: 19210674
    [Abstract] [Full Text] [Related]

  • 20. [Cancer of the prostate: advances in the use of PSA and its derived indices--new tumor markers].
    Zlotta A, Schulman C.
    Rev Med Brux; 1999 Sep 01; 20(4):A201-5. PubMed ID: 10523893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.